Documents | Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza | Guidance

A list of downloadable documents created during development.

Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza

Background information

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: appendix A - GE decision paper - October 2014 04 December 2014 290.38 KB

Appendix A - provisional matrix of stakeholders 03 June 2014 102.96 KB

Appendix B - addendum to the review considerations for TA158 and TA168 03 June 2014 146.11 KB

Appendix C - consultee and commentator comments on TA168 proposal 03 June 2014 102.08 KB

Appendix A: decision paper presented to the Institute's Guidance Executive 28 November 2011 78.64 KB

Appendix A: provisional matrix of stakeholders 06 October 2011 68.45 KB

Appendix B: proposal paper presented to the Institute's Guidance Executive 06 October 2011 280.31 KB

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: final appraisal determination

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: final appraisal determination 08 August 2008 126.13 KB

Response to consultee, commentator and public comments on the ACD and comments from website consultation 08 August 2008 81.73 KB

Consultee and commentator comments on the ACD

Manufacturer/sponsor: GlaxoSmithKline 08 August 2008 10.79 KB

Manufacturer/sponsor: Roche 08 August 2008 89.13 KB

Professional and patient groups: British Thoracic Society 08 August 2008 14.72 KB

Professional and patient groups: Diabetes UK 08 August 2008 40.42 KB

Professional and patient groups: General Practice Airways Group 08 August 2008 40.92 KB

Professional and patient groups: Health Protection Agency 08 August 2008 22.81 KB

Professional and patient groups: Royal College of Paediatrics and Child Health 08 August 2008 61.86 KB

Professional and patient groups: Royal College of Physicians 08 August 2008 10.95 KB

Professional and patient groups: Royal College of Nursing 08 August 2008 19.57 KB

Others: Department of Health 08 August 2008 11.42 KB

Others: NHS Quality Improvement Scotland 08 August 2008 19.8 KB

Others: Welsh Assembly Government 08 August 2008 27.07 KB

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: appraisal consultation

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: appraisal consultation

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: evaluation report

Evaluation report: overview 16 May 2008 85.29 KB

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: assessment report 16 May 2008 1.31 MB

Consultee and commentator comments on the assessment report

Consultee and commentator comments on the assessment report: British Thoracic Society 16 May 2008 18.42 KB

Consultee and commentator comments on the assessment report: Diabetes UK 16 May 2008 44.89 KB

Consultee and commentator comments on the assessment report: GlaxoSmithKline 16 May 2008 27.21 KB

Consultee and commentator comments on the assessment report: Roche 16 May 2008 97.5 KB

Consultee and commentator comments on the assessment report: Royal College of Nursing 16 May 2008 13.05 KB

Consultee and commentator comments on the assessment report: Royal College of Physicians 16 May 2008 13.53 KB

Non-manufacturer submissions

Non-manufacturer submissions: British Thoracic Society 16 May 2008 54.58 KB

Non-manufacturer submissions: Diabetes UK 16 May 2008 60.79 KB

Non-manufacturer submissions: Health Protection Agency 16 May 2008 76.45 KB

Non-manufacturer submissions: Royal College of Nursing 16 May 2008 13.98 KB

Non-manufacturer submissions: Royal College of Physicians 16 May 2008 42.21 KB

Manufacturer submissions (executive summary only)

Manufacturer submissions (executive summary only): Roche 16 May 2008 556.11 KB

Manufacturer submissions (executive summary only): GlaxoSmithKline 16 May 2008 159.29 KB

Manufacturer submissions (executive summary only): Alliance Pharmaceuticals 16 May 2008 14.45 KB

Expert written personal statements

Expert written personal statements: Fleming 16 May 2008 140.55 KB

Expert written personal statements: Gunaratnam 16 May 2008 30.64 KB

Expert written personal statements: Watson 16 May 2008 25.79 KB

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: provisional matrix of consultees and commentators

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: provisional matrix of consultees and commentators 10 July 2007 38.83 KB

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: draft scope

Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir: draft scope 10 July 2007 46.72 KB